Skip to main content
Menu
search
0

Accreditations & awards

At Sphere Fluidics, we're committed to delivering high-quality products & services. Our awards & accreditations demonstrate our dedication to excellence.

Excellence is Our Standard

Quality is at the heart of everything we do. We’re dedicated to exceeding industry standards and continuously improving. Our numerous awards and accreditations attest to our commitment to excellence in all aspects of our business, ensuring our clients receive the highest-quality products and services.

Scientist with swoosh in background

Accreditations

Sphere Fluidics Ltd - ISO 9001 - Logo

ISO9001:2015 Accreditation for Life Sciences Products and Services

IASME Cyber Essentials Accreditation Logo

IASME Cyber Essentials Accreditation

Silver Accreditation (We invest in People) from Investors in People.

Other accreditations include:

  • 21 CFR Part 11 accreditation for Cyto-Mine® software
  • UL Accreditation for Cyto-Mine®
  • IASME Cyber Security Accreditation
  • IASME Cyber Security and GDPR-Compliance

Awards & Nominations

Since 2010, the Sphere Fluidics team are proud to have received over 60 awards and commendations – a reflection of our commitment to excellence

IP100 award logo

IP100 Awards 2017: Top 10 Awards for Patents

The Scientist names Cyto-Mine® Number One in its Top 10 Innovations of 2018.

The Scientist names Cyto-Mine® Number One in its Top 10 Innovations of 2018

Finalist - IChemE Global Biotechnology Award 2019

Finalist - IChemE Global Biotechnology Award 2019

Queen’s Award for Enterprise (Innovation). 2020

Queen’s Award for Enterprise (Innovation). 2020

Winner - Frost and Sullivan: European Technology Innovation Leadership Award 2022

Winner - Frost and Sullivan: European Technology Innovation Leadership Award 2022

Other awards include:

  • Nominee – East of England’s Business Weekly “Killer 50” companies. 2010
  • Winner – prize for “Killer Technology” by Business Weekly for the company with the best science and technology. 2011
  • Winner – European ACES Entrepreneurial Prize for “Best University Life Sciences Spin-Out”. 2013
  • Nominee – Finalist in two of the 2013 UK Business Angels Association Awards. 2013
  • Winner – Acquisition International Award for “Best UK Early Stage Investment”. 2013
  • Shortlisted – “Genesis BioNewsRound 2014 Award”. 2014
  • Nominee – Real Business “UK’s Top 50 Disruptive SMEs”. 2015
  • Finalist – UKBAA “Best Investment – High Growth Manufacturing.” 2015
  • Finalist – Business Weekly “Life Sciences Innovation Award”. 2015
  • Winner – Corporate LiveWire Excellence and Innovation Award for Life Sciences. 2015
  • Nominee – member of the UK IP100 (a UK intellectual property league). 2015
  • One to Watch” in the Biotech and Money Showcase. 2016
  • Cited as a case study in the UK Synthetic Biology Strategic Plan. 2016
  • Won a place to join the London Stock Exchange “ELITE Program”. 2016
  • Global Health and Pharma’s “Best UK Company for Life Sciences R&D Applications”. 2016
  • Joined Innovate UK’s “Growth Showcase”. 2016
  • Finalist – in UKBAA’s “Best Investment in Medtech” Award. 2016
  • Featured in Innovate UK “Innovate with Impact” publication. 2016
  • Winner – New Product Innovation Award” for Cyto-Mine® at Basel MipTec Conference. 2016
  • Winner – Top Innovation 2016” Award from Cambridge News.
  • Winner – Corporate LiveWire “Most Outstanding Life Sciences R&D Applications”. 2016
  • Accepted onto the London Mayor’s International Business “Go to Grow” Programme. 2017
  • Winner – UK Business Angel Association “2017 Best Life Sciences Investment Award”.
  • Winner = Corporate Insider “2017 Biopharmaceutical Technology Firm of the Year Award”.
  • Winner – Frost and Sullivan European Award for New Product Innovation. 2017
  • Finalist – One Nucleus 2017 BioNewsRound Awards.
  • Highly Commended” in the SME National Business Awards for Business Innovation. 2017
  • “One to Watch” in the European Business Awards for Business Innovation. 2017
  • Winner – Red Herring Top 100 Europe Award. 2018
  • IP 100 UK 2018: UK Top 20 Entrants in their IP League. Best in Patents IP Asset Class.
    IP 100 UK 2023: Top 10 in the IP 100 Dynamic IP League Table.
  • Nominee – Cambridge Business Weekly: SF Nominated as a “One to Watch”. 2018
  • Nominee – Cambridge Independent Science and Technology Awards: SF Nominated as a “One to Watch”. 2018
  • Nominee – The Silicon Review: SF Nominated as “Top 30 Best Small Companies to Watch”. 2018
  • Finalist – the Medicine Makers’ “Innovation Awards 2019”.
  • IP100 2019 Awards: IP100 Top 20 IP Companies (number 7). IP100 Top 20 Patents (number 8). IP100 Top 20 Trade Secrets (number 2). IP100 Top 20 Critical Databases (number 11).
  • Shortlisted in the Royal Academy of Engineering 2021 MacRobert Award. 2021
  • IP100 2020 Awards: IP100 Top 20 IP Companies (number 9). IP100 Top 20 Patents (number 9). IP100 Top 20 Trade Secrets (number 2). IP100 Top 20 Critical Databases (number 18).
  • Second in International Trade Councils 2021 Go Global Award (Biotech – Export). 2021
  • Winner – Cambridge Business Weekly “Killer50 Bridge Company” Award. 2022
  • Cambridge Business Weekly: “Mover and Shakers” List. 2023
  • Sifted: Top 15 fastest-growing University spin-out companies in Europe (by headcount) 2023
  • Winner – Global Health & Pharma Global Excellence Awards: Best Life Sciences R&D Company 2023 – UK

Got a question?

Want to learn more about us and our products?
Get in touch with our team!

Get to Know Us

Curious about the people behind Sphere Fluidics?
Find out more about us